- Our Focus
- Team
- Pipeline
- details
- LYT-100
- Digital Medicine for CNS Disorders
- Vocal Biomarkers to Monitor and Manage CNS Disorders
- Immunotherapies for Aging-Related Diseases
- Selective Muscarinic Receptor Targeting for CNS Disorders
- Regenerative Biology Platform for Androgenetic Alopecia
- Microbiome-Derived Modulators for Immune and Infectious Disease
- Targeted Disease Immunomodulation for Acute and Chronic Inflammatory Disorders
- Microbiome-Derived Modulators for Pediatric and Maternal Immune Disease
- Unleashing Targeted Immunotherapy for Heme Malignancies
- Immunosuppressive Gamma Delta T-Cells
- Milk Exosomes Technology
- Hydrogel Platform Technology For GI Related Diseases
- Engineered Hydrogels to Enable Oral Delivery of Peptides
- Lymphatic Targeting Technology
- CNS Lymphatics Technology
- LYT-200
- LYT-210
- Lymphatic therapeutics program 1
- Lymphatic therapeutics program 2
- Lymphatic therapeutics program 3
- details
- News
- Investors
